there have been no statistically significant differences noted among the groups in terms of the probability of disease-free survival or survival , and 82.7 % of all patients are alive at 30 mo ( 84.6 % cvp , 73 % cvp-tli , and 90 % sa ) .
C0010583
cvp
C0056633
cvp-tli